Formerly the Head of Life Sciences at Hay Group, Ian is now Head of People and Performance at ZS Associates. With over twenty-five years of management consulting experience, Ian has worked closely with executives as they assess the tradeoffs and challenges associated with a successful launch. Ian’s launch and early-stage experience has been extensive. He has focused on helping senior executives identify the capabilities – both organization and people – that are needed to execute on early stage launch success. Ian’s experience in this arena has spanned over seventeen years, beginning with ICOS, and more recently working with early commercial stage companies in the areas of NASH, Dermatology, and Rare Diseases. He has worked closely with management and Boards to share a commercialization approach that balances the financial constraints facing early-stage companies, while acknowledging the importance of gaining traction early in the launch phase. Ian recognizes that launch presents a number of uncertainties — market, regulatory, financial and – not the least to be acknowledged – the inherent nature of the product and its potential side effect profile. Preparing management and the Board for uncertainty and unpredictability is an essential capability that successful early stage players have mastered.